600713.SH
Nanjing Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Medical - Distribution · CN
CNY 5.16
−0.77%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 4.96
From 52W high−19.37%
Volume9.48M
Market capCNY 6.75B
P/E (TTM)10.8x
P/S (TTM)0.1x
Div yield5.17%
Key dataSep 18, 2026
Open
CNY 4.96
From 52W high
−19.37%
Volume
9.48M
Market cap
CNY 6.75B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
8.0x
P/E (TTM)
10.8x
RSI (14)
40.3
MomentumView details →
1D Return
−0.77%
YTD Return
−7.88%
Similar companies
Latest newsMore news →
Nanjing Pharmaceutical's non-independent director Zuo Xiangyuan resigned due to work changes, and the controlling shareholder nominated Huang Cheng as a candidate for the 10th board of directors.13d agoNanjing Pharmaceutical Co., Ltd. announced a cash dividend of 0.9 yuan per 10 shares (tax included), with total distribution of 118 million yuan based on total share capital of 1.308 billion shares.23d ago